AU2001285820A1 - Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors - Google Patents

Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors

Info

Publication number
AU2001285820A1
AU2001285820A1 AU2001285820A AU8582001A AU2001285820A1 AU 2001285820 A1 AU2001285820 A1 AU 2001285820A1 AU 2001285820 A AU2001285820 A AU 2001285820A AU 8582001 A AU8582001 A AU 8582001A AU 2001285820 A1 AU2001285820 A1 AU 2001285820A1
Authority
AU
Australia
Prior art keywords
ovarian
diagnostic
adhesion molecule
methods based
therapeutic methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001285820A
Other languages
English (en)
Inventor
Peter Altevogt
Mina Fogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
German Cancer Research Center
Mor Research Applications Ltd
Original Assignee
German Cancer Research Center
Mor Research Applications Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by German Cancer Research Center, Mor Research Applications Ltd filed Critical German Cancer Research Center
Publication of AU2001285820A1 publication Critical patent/AU2001285820A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001285820A 2000-07-10 2001-07-10 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors Abandoned AU2001285820A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00114788A EP1172654B1 (en) 2000-07-10 2000-07-10 Diagnostic method based on the detection of the L1 adhesion molecule for ovarian and endometrial tumors
EP00114788.3 2000-07-10
PCT/EP2001/007924 WO2002004952A2 (en) 2000-07-10 2001-07-10 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors

Publications (1)

Publication Number Publication Date
AU2001285820A1 true AU2001285820A1 (en) 2002-01-21

Family

ID=8169210

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001285820A Abandoned AU2001285820A1 (en) 2000-07-10 2001-07-10 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors

Country Status (10)

Country Link
US (2) US7618785B2 (cg-RX-API-DMAC7.html)
EP (2) EP1172654B1 (cg-RX-API-DMAC7.html)
JP (1) JP5165827B2 (cg-RX-API-DMAC7.html)
CN (1) CN1479871A (cg-RX-API-DMAC7.html)
AT (1) ATE377192T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001285820A1 (cg-RX-API-DMAC7.html)
CA (1) CA2415364C (cg-RX-API-DMAC7.html)
DE (1) DE60036935T2 (cg-RX-API-DMAC7.html)
ES (1) ES2296586T3 (cg-RX-API-DMAC7.html)
WO (1) WO2002004952A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2296586T3 (es) * 2000-07-10 2008-05-01 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Metodo de diagnostico basado en la deteccion de la molecula de adhesion l1 para tumores de ovario y el endometrio.
US6852874B2 (en) 2000-10-02 2005-02-08 The Scripps Research Institute Second cycle asymmetric dihydroxylation reaction
EP1623995A1 (en) 2004-08-06 2006-02-08 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Inhibitors of L1 and ADAM10 for the treatment of carcinomas
WO2007114550A1 (en) * 2006-04-03 2007-10-11 Korea Research Institute Of Bioscience And Biotechnology A novel monoclonal antibody specific to the l1cam, a hybridoma producing the same and a method producing the same
AU2007288620B2 (en) 2006-08-23 2012-08-30 Korea Research Instititute Of Bioscience And Biotechnology A pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma
WO2008151819A2 (en) * 2007-06-15 2008-12-18 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Treatment of tumors using specific anti-l1 antibody
AU2008201871A1 (en) * 2008-04-16 2009-11-26 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts Inhibition of angiogenesis and tumor metastasis
KR20100060351A (ko) 2008-11-27 2010-06-07 한국생명공학연구원 L1cam의 활성 또는 발현을 억제하는 물질 및 항암제를포함하는 항암용 조성물
KR101504039B1 (ko) * 2012-11-16 2015-03-19 강원대학교산학협력단 인간 및 마우스 l1cam 단백질에 특이적으로 결합하는 항체 및 이의 용도
KR20250140647A (ko) * 2020-08-03 2025-09-25 난트셀, 인크. Il-15 초작용제에 대한 약물-특이적 약동학 검정

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939240A (en) * 1983-03-04 1990-07-03 Health Research, Inc. Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy
GB2339200B (en) * 1998-06-06 2001-09-12 Genostic Pharma Ltd Genostics
ES2296586T3 (es) * 2000-07-10 2008-05-01 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Metodo de diagnostico basado en la deteccion de la molecula de adhesion l1 para tumores de ovario y el endometrio.
US20020115065A1 (en) * 2000-08-28 2002-08-22 Ton Logtenberg Differentially expressed epitopes and uses thereof
EP1399850A2 (en) * 2001-02-21 2004-03-24 The Board of Regents of The University of Oklahoma Hla ligand database utilizing predictive algorithms and methods of making and using same

Also Published As

Publication number Publication date
US7670601B2 (en) 2010-03-02
CA2415364C (en) 2009-02-24
WO2002004952A2 (en) 2002-01-17
DE60036935T2 (de) 2008-08-21
CA2415364A1 (en) 2002-01-17
JP5165827B2 (ja) 2013-03-21
EP1172654A1 (en) 2002-01-16
DE60036935D1 (de) 2007-12-13
US7618785B2 (en) 2009-11-17
EP1172654B1 (en) 2007-10-31
ES2296586T3 (es) 2008-05-01
JP2004513074A (ja) 2004-04-30
EP1386162A2 (en) 2004-02-04
CN1479871A (zh) 2004-03-03
ATE377192T1 (de) 2007-11-15
WO2002004952A3 (en) 2003-11-06
US20080138331A1 (en) 2008-06-12
US20040259084A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
CA2384579A1 (en) Early cancer tumor marker
WO2002035232A3 (en) Method for detecting ovarian cancer based on human kallikrein 6 (hk6)
AU3838899A (en) Tumour markers
AU3926797A (en) Determination of cPSA
AU1740700A (en) Method and apparatus for performing a lateral flow assay
CA2137822A1 (en) Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes
AU4085097A (en) Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
WO2000056352A3 (en) Reagents and methods useful for detecting diseases of the prostate
AU7158796A (en) Compounds and methods for diagnosis of tuberculosis
WO1999041584A3 (en) METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
AU1671300A (en) Cancer detection method and reagents
WO2002037112A3 (en) Detection of ovarian cancer
WO1998016645A3 (en) Compounds and methods for diagnosis of tuberculosis
NZ338068A (en) Diagnosis of early gastric cancer detecting cyclooxygenase-2 mRNA expression or Cox-2 protein overexpression
WO2004031414A3 (en) Method for diagnosing prostate cancer
IL146454A0 (en) METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
WO2003040347A3 (en) Baalc expression as a diagnostic marker for acute leukemia
WO2002004952A3 (en) Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors
AU1370592A (en) Immunoassay for detection of mutant p53 polypeptide in biological fluids
WO2003052121A3 (en) Method of reducing angiogenesis
ZA92264B (en) Prescreening of prostate cancer by serum prostatic specific antigen.
WO1998021365A3 (en) Method for detection of metastatic prostate cancer
WO2001004343A3 (en) A method for determining the prognosis of cancer patients by measuring levels of bag expression
EP0899541A3 (en) Apparatus for determining the thickness of an optical sample
AU4865997A (en) Monoclonal antibodies against a human act and serine protease complex